Advanced HCC: Patients not eligible for IO - What are the treatment options?
Prof. Dr James Harding, Medical Oncologist at Memorial Sloan Kettering Cancer Center and Prof. Dr Sammy Saab, Gastroenterologist and Transplant Hepatologist at the David Geffen School of Medicine, bot...
6 Joulu 202324min
Prostate cancer: PARP inhibitors. Part 2 - Combination therapy; US and EU perspectives
Dr Neal Shore, Uro-Oncologist and Chief Medical Officer for Genesis Care and Urology and Surgical Oncology in the United States and Dr Elena Castro, Medical Oncologist at Hospital Universitario 12 de ...
6 Joulu 202319min
Prostate cancer: PARP inhibitors. Part 1 - PARPi monotherapy; US and EU perspectives
Dr Neal Shore, Uro-Oncologist and Chief Medical Officer for Genesis Care and Urology and Surgical Oncology in the United States and Dr Elena Castro, Medical Oncologist at Hospital Universitario 12 de ...
6 Joulu 202321min
Endometrial carcinoma: Systemic therapies. Part 1 - The physicians' perspective
Join world-renowned gynaecological oncology experts Dr Domenica “Ketta” Lorusso and Dr Mansoor Mirza as they explore the changing landscape of systemic treatment in endometrial carcinoma. Single-agent...
6 Joulu 202329min
Lower GI cancer: Highlights from ASCO GI 2023 - Part 2
This episode, covers the highlights on colorectal cancer from ASCO GI 2023. Prof. Andrea Sartore-Bianchi (Niguada Cancer Center, Milan, Italy) and Prof. Shubham Pant (MD Anderson Cancer Center, Houst...
6 Joulu 202324min
Upper GI cancer Highlights from ASCO GI 2023 - Part 1
This episode, covers the highlights on gastroesophageal, gastric and gastroesophageal junction (GEJ) cancer from ASCO GI 2023. Dr Nataliya Uboha (University of Wisconsin, USA) and Dr Efrat Dotan(Fox ...
6 Joulu 202325min
Sarcoma: Updates from CTOS 2022
In this podcast, Prof. Jonathan Trent and Prof. Robin Jones discuss what’s new in the patient management in sarcoma from CTOS 2022. The Connective Tissue Oncology Society is an international group of ...
6 Joulu 202322min
Advanced RCC: Clinical implementation of targeted therapies and immunotherapies
Prof. Thomas Powles, a Medical Oncologist from Barts Cancer Centre in the UK and Dr Friederike Schlürmann a Medical Oncologist from University Hospital of Brest and Quimper in France, discuss the clin...
6 Joulu 202319min
